Canadian experience with two triphasic oral contraceptive formulations
Most of the scientific community and the public recognize the importance of steroidal contraception and the improvements which have been made in their formulation. There is evidence that reduced dosage has been associated with a reduction of side-effects, including those of a more serious nature. At the same time, the prohibitive cost of new drug development, in time, manpower and economic terms, makes it essential to extract the maximum value from those steroids currently in use. Thus the search continues to produce a formulation which maintains efficacy and cycle control and which provides the least disruption of normal metabolic processes.
KeywordsHigh Density Lipoprotein Cholesterol 12th Cycle Prohibitive Cost Canadian Experience Total Oestrogen
Unable to display preview. Download preview PDF.
- 1.Arnt, I. C., Ferrari, A., Sartoretto, J. N and Woutersz, T.D. (1977). Fertil. Steril, 28,549Google Scholar
- 2.Schneider, W. H. P., Spona, J., Schmid, R. and Lachnit-Fiason, U. (1977). In Haspels, A. A. and Kay, C. R..(eds.), International Symposium on Hormonal Contraception. ( Amsterdam: Excerpta Medica )Google Scholar
- 3.Zador. G. (1979). Acta Obstel Gynecrol. Scand Suppl., 88, 43Google Scholar